quantitative
Analysis v1
Strong Opposition
Taking GLP-1 drugs like Ozempic doesn’t seem to lower the chance of having a stroke for people who are overweight or obese but don’t have diabetes, at least compared to taking a dummy pill.
0
65
Evidence from Studies
Supporting (0)
0
Community contributions welcome
No supporting evidence found
Contradicting (1)
65
Community contributions welcome
65
Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis
Systematic Review With Meta-Analysis
Human
2024The study found that GLP-1 drugs lower the risk of heart problems in overweight people without diabetes, which goes against the claim that they don’t help prevent strokes.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.